- Home
- REX vs DNA Comparison
REX vs DNA Comparison
Compare REX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REX
- DNA
- Stock Information
- Founded
- REX 1980
- DNA 2008
- Country
- REX United States
- DNA United States
- Employees
- REX N/A
- DNA N/A
- Industry
- REX Major Chemicals
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REX Industrials
- DNA Health Care
- Exchange
- REX Nasdaq
- DNA Nasdaq
- Market Cap
- REX 644.0M
- DNA 562.1M
- IPO Year
- REX N/A
- DNA N/A
- Fundamental
- Price
- REX $35.55
- DNA $5.30
- Analyst Decision
- REX Strong Buy
- DNA Sell
- Analyst Count
- REX 1
- DNA 5
- Target Price
- REX $50.00
- DNA $17.25
- AVG Volume (30 Days)
- REX 147.4K
- DNA 1.3M
- Earning Date
- REX 05-21-2025
- DNA 05-08-2025
- Dividend Yield
- REX N/A
- DNA N/A
- EPS Growth
- REX N/A
- DNA N/A
- EPS
- REX 3.30
- DNA N/A
- Revenue
- REX $642,491,000.00
- DNA $227,043,000.00
- Revenue This Year
- REX $3.27
- DNA N/A
- Revenue Next Year
- REX $17.11
- DNA $19.36
- P/E Ratio
- REX $11.01
- DNA N/A
- Revenue Growth
- REX N/A
- DNA N/A
- 52 Week Low
- REX $35.40
- DNA $5.26
- 52 Week High
- REX $60.60
- DNA $47.60
- Technical
- Relative Strength Index (RSI)
- REX 32.82
- DNA 30.74
- Support Level
- REX $37.11
- DNA $5.35
- Resistance Level
- REX $39.17
- DNA $6.20
- Average True Range (ATR)
- REX 1.34
- DNA 0.48
- MACD
- REX -0.02
- DNA -0.00
- Stochastic Oscillator
- REX 0.00
- DNA 4.78
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.